Despite President Trump’s assertions that his deals with drugmakers would lower prescription drug prices, a Senate Democratic report indicates prices have continued to rise, with some medications experiencing sharp increases. Companies that entered into agreements with the administration have reportedly raised the cost of hundreds of drugs and launched new ones at an average annual price of $353,000. These price hikes affect critical treatments such as gene therapies and cancer medications, while the companies themselves have seen significant profit increases. The report raises concerns about the effectiveness and transparency of the administration’s pricing strategies, with critics arguing that these efforts may have primarily benefited drug companies rather than consumers.
Read More
A new Senate report has uncovered 510 credible allegations of human rights abuses within U.S. immigration detention centers, including 14 cases of mistreatment of pregnant women. The investigation, spearheaded by Senator Jon Ossoff, revealed serious issues such as inadequate medical care, poor living conditions, and delayed treatment, specifically highlighting instances where pregnant women were denied urgent care and proper nutrition. The report documents a range of distressing incidents, including a case where a woman was left unattended after a miscarriage, underscoring the severity of the reported abuses. Despite these findings, a Department of Homeland Security official maintains that all detainees receive proper medical care and screenings.
Read More
A U.S. Senate investigations subcommittee report revealed the Department of Government Efficiency (DOGE), implemented by Elon Musk, wasted over $21 billion in its first six months. The report highlighted significant waste from mass layoffs of federal employees, resulting in $14.8 billion spent on early retirement packages and $6.1 billion on severance. Furthermore, DOGE’s funding freezes led to lost interest payments, spoiled goods, and cuts to programs that generated more revenue than they cost to operate. This included the Consumer Financial Protection Bureau (CFPB), and public health research cuts. Long-term projections suggest that the DOGE initiatives could cost taxpayers significantly more in the future.
Read More
A new Senate report details how Elon Musk, during his 130 days as a Trump administration employee, leveraged his access to advance his business interests. The report, authored by Senator Elizabeth Warren, cites over 130 instances where Musk, his companies, and family members engaged in actions raising ethical and conflict-of-interest concerns, ranging from securing lucrative contracts to hindering regulatory oversight. While not all actions are illegal, the report argues Musk violated established norms at an unprecedented rate, harming the public interest. The report categorizes these actions across fifteen areas, including White House promotion of Tesla, securing government contracts, and stifling investigations into his companies.
Read More
A Senate Democratic report alleges that Elon Musk leveraged his influence within the Trump administration to significantly reduce potential financial liabilities for himself and his companies, including SpaceX, Tesla, and others. This influence manifested in a broad campaign to weaken federal agencies and reduce oversight. The report details at least 65 “actual or potential” regulatory actions totaling over $2.37 billion in potential liabilities facing Musk’s companies on Trump’s inauguration day. Democrats contend Musk used his power to obstruct investigations and avoid accountability.
Read More
John Q. Hosedrinker